Published in

International Union Against Tuberculosis and Lung Disease, International Journal of Tuberculosis and Lung Disease, 8(22), p. 905-911

DOI: 10.5588/ijtld.17.0837

International Union Against Tuberculosis and Lung Disease, International Journal of Tuberculosis and Lung Disease, 3(23), p. 358-362, 2019

DOI: 10.5588/ijtld.16.0837

Links

Tools

Export citation

Search in Google Scholar

Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay

Journal article published in 2019 by K. Schnippel, R. Kularatne, Rebecca H. Berhanu ORCID, C. K. Lippincott, C. Firnhaber, C. R. Horsburgh, Karen R. Jacobson ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO